Home / Health / New Injection Offers Heart Failure Relief at Home
New Injection Offers Heart Failure Relief at Home
29 Jul
Summary
- A new self-administered injection for heart failure fluid buildup has been approved.
- The injection delivers furosemide to reduce excess body water and electrolytes.
- An experimental blood test can now detect tuberculosis at earlier stages.
Patients in the U.S. with heart failure or kidney disease experiencing fluid overload will soon be able to manage their condition at home. A newly approved under-the-skin autoinjector, Furoscix ReadyFlow, delivers furosemide, a diuretic that helps the body eliminate extra water and electrolytes, offering an alternative to emergency room infusions. This device, developed by MannKind, received U.S. approval last week and is expected to be commercially available by the end of August.
Meanwhile, a significant advancement in tuberculosis diagnosis has been reported. Researchers have developed an experimental blood test capable of detecting TB at varying exposure levels, a critical improvement as current methods often rely on sputum analysis, which not all patients can provide. This new biosensor can sensitively detect a bacterial marker, ESAT-6, directly from the TB bacteria, distinguishing active TB from latent infection or exposure with high accuracy.
